Amgen Posts Weak Results, but Hails Osteoporosis Drug
119762
The biotechnology company said Thursday that its experimental osteoporosis drug proved superior to Fosamax from Merck in a clinical trial.
543431
Drugs that treat anemia caused by kidney failure provide important benefits despite the risks for some patients at high doses, Amgen Inc. told a U.S. advisory panel on Tuesday.
454431
The drug company's experimental treatment for Alzheimer's  failed to prove effective in a big clinical trial. The stock  closed Tuesday at $45.85 on the New York Stock Exchange before  falling 10 percent in after-hours trading following release of  the trial results.
382922
For the first time, an osteoporosis drug has reduced deaths and prevented new fractures in elderly patients with broken hips, according to new research. Some experts called the drop in deaths "striking" but said other drugs could have a similar effect.
44172
Biotech giant Inc. Amgen and the pharmaceuticals division of health-care products company Wyeth said Tuesday the Food and Drug Administration approved their arthritis treatment Enbrel to induce a major clinical
725490
Genelabs Technologies Inc. GNLB.O  said on Tuesday that a late-stage trial of its drug to limit  bone loss in women with lupus disease failed to work, sending  the company's shares down 75 percent.
255353
Amgen Inc. , the world's biggest biotechnology company, on Wednesday reported a lower third-quarter profit related to the acquisition of another biotech company.
751523
A new addition to an already successful drug promises good results for investors.
304071
Biogen releases its third-quarter financial results.
289377
Amgen Inc. AMGN.O, the world's  biggest biotechnology company, on Wednesday reported a lower  third-quarter profit related to the acquisition of another  biotech company.
295591
A drug used to treat bone marrow cancer may also help treat osteoporosis by stimulating stem cells, U.S. researchers reported on Friday.
7824
Study indicates potential of alendronate and estrogen progression of osteoarthritis - Osteoarthritis (OA) of the knee, a chronic inflammatory disease marked by cartilage degradation and bone abnormalities, is a leading cause of disability among elderly
300389
Amgen  reported on Thursday that its fourth-quarter profit edged higher as cost cutting helped offset declining sales of its anemia drugs that have been hit with safety concerns and new restrictions on their use and insurance reimbursements.
63381
Biotech giant Amgen Inc. reported Thursday that its fourth-quarter profits rose, topping analysts' estimates, despite government warnings about the safety of its popular anemia drugs.
188476
Its unique compound to fight the growth of cancer cells fails in trials.
449015
Amgen Inc  reported sharply lower third-quarter profit on Wednesday on falling sales from its important anemia drugs, amid new insurance coverage restrictions and safety concerns, and on restructuring charges.
97646
The Motley Fool - As investors waited anxiously for Amgen's (Nasdaq: AMGN - News) earnings report, the United Kingdom's high court snuck in with a stinker. It ruled that Transkaryotic Therapies (Nasdaq: TKTX - News) and Sanofi-Aventis (NYSE: SNYT - News) did not infringe on the patent for EPO, Amgen's anemia treatment (which accounts for 27% of its sales), and ruled the patent invalid.